PathAI and Rede D’Or Join Forces to Advance AI-Driven Pathology in Brazil

PathAI, a pioneer in AI-powered pathology solutions, has announced a strategic partnership with Rede D’Or, Brazil’s largest hospital network, to bring advanced digital pathology to the country. This collaboration marks PathAI’s entry into South America, equipping Rede D’Or’s 78 hospitals with cutting-edge AI technology to enhance diagnostic precision and efficiency. By integrating PathAI’s AISight® platform, which includes the AIM-Breast Biomarker panel for ER, PR, HER2, and Ki67 quantification, Rede D’Or aims to modernize pathology workflows and expand research capabilities.

As Rede D’Or continues its R$7.5 billion expansion to over 125 facilities, this partnership underscores its commitment to innovation in healthcare. Dr. Fernando Soares, a leading pathologist at Rede D’Or, emphasized the importance of AI in advancing oncology diagnostics, while PathAI’s CEO, Dr. Andy Beck, highlighted the collaboration as a milestone for AI adoption in Latin America. By leveraging AI-driven insights, both organizations are setting new standards in pathology, improving disease detection, and paving the way for better patient outcomes across Brazil.